BRAF V600E
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
BRAF V600E
Apr 20, 2024, 06:18 |
Insight
New Paper Alert! Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer
Addressing BRAF V600E in Metastatic Non-Small Cell Lung Cancer Authors: David Planchard, Rachel E. Sanborn,…
Apr 20, 2024, 06:08 |
Insight
David Planchard: Some advances for our BRAF V600E NSCLC patients…Review to read at npj Journals
David Planchard, Professor at the University of Paris-Saclay, posted on X/Twitter: "Some advances for our BRAF…
Apr 18, 2024, 09:40 |
Insight
Chiara Cremolini: New real world data about BRAF mutant mCRC. What are we doing after the targeted therapy?
Chiara Cremolini, Associate Professor in Medical Oncology at the University of Pisa, shared a post…
Apr 17, 2024, 13:11 |
Insight
New Paper Alert! Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal Cancer: A Real-World Analysis
New Paper Alert: Exploring Treatment Strategies After Progression to BRAF V600E-Targeted Therapy in Metastatic Colorectal…
Apr 14, 2024, 11:39 |
Drugs
Nieves Martinez Lago: FDA approvals Tumor-Agnostic drugs
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared on X/Twitter: "FDA…
All:
5
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube